Business Description
NanoenTek Inc
ISIN : KR7039860002
Compare
Compare
Traded in other countries / regions
039860.Korea IPO Date
2000-08-16Description
NanoenTek Inc is a South Korea-based company. It is engaged in the development and sale of life science experiment equipment, medical in-vitro diagnostic devices, point of care diagnostic devices, and related solutions. It provides live cell movie analyze products, including JuLI Br, a live cell movie analyzer; JuLI FL, a fluorescence live cell movie analyzer that enables users to perform image capturing and the time-lapse movie making; and JuLI Stage, a real-time cell history recorder for live cell imaging and analysis. The company also provides for the life science industry.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 67.36 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.67 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 11.93 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.4 | |||||
| 3-Year EBITDA Growth Rate | -33.4 | |||||
| 3-Year Book Growth Rate | 5.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.56 | |||||
| 9-Day RSI | 40.23 | |||||
| 14-Day RSI | 38.51 | |||||
| 6-1 Month Momentum % | 11.19 | |||||
| 12-1 Month Momentum % | -25.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.34 | |||||
| Quick Ratio | 7.12 | |||||
| Cash Ratio | 5.17 | |||||
| Days Inventory | 241.55 | |||||
| Days Sales Outstanding | 82.66 | |||||
| Days Payable | 26.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.19 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.99 | |||||
| Operating Margin % | -8.31 | |||||
| Net Margin % | -13.71 | |||||
| FCF Margin % | -7.38 | |||||
| ROE % | -6.62 | |||||
| ROA % | -6.08 | |||||
| ROIC % | -19.54 | |||||
| ROC (Joel Greenblatt) % | -8.36 | |||||
| ROCE % | -3.66 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.28 | |||||
| PB Ratio | 1.65 | |||||
| Price-to-Tangible-Book | 1.69 | |||||
| EV-to-EBIT | -32.12 | |||||
| EV-to-EBITDA | 137.21 | |||||
| EV-to-Revenue | 2.47 | |||||
| EV-to-FCF | -32.53 | |||||
| Price-to-Projected-FCF | 1.35 | |||||
| Price-to-Median-PS-Value | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 2.54 | |||||
| Price-to-Net-Cash | 5.19 | |||||
| Earnings Yield (Greenblatt) % | -3.11 | |||||
| FCF Yield % | -2.25 | |||||
| Forward Rate of Return (Yacktman) % | 4.19 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers